Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]
Welcome David Ríos Covián, Director of Technology Development, on board. David obtained his BS in Biology (2010) and MS (2011) in Food Biotechnology at the University of Oviedo. In addition, he obtained his PhD (2016) [...]
Microviable Therapeutics is celebrating World Microbiome Day 2023! We share how important microbes are for the health of humans, animals, plants, oceans and the entire planet. Through increased awareness and education we can create a [...]
Microviable Therapeutics Research Scientist Pilar Manrique will be presenting at Microbiome Connect Europe 2023 taking place on July 5th-6th at Amsterdam. Pilar will discuss "A path to develop a donor-based microbiome therapeutic product". Microbiome Connect [...]
Microviable Therapeutics will be presenting at the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. Noelia Martínez, R&D Director, Pilar Manrique, Research Scientist and Marta F. Gosende, Research [...]
Microviable Therapeutics is thrilled to announce that will be attending the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. The event will bring together academic, industry, and investment [...]
Microviable welcomes to the team our new internship student Alejandro Ojeda Suárez, Biologist with a Master's in Physiology and Clinical and Biomedical Laboratory Technician.
We are looking for a full-time, highly motivated lab technician to work on our team on-site (Oviedo, Asturias, Spain). The ideal candidate will have experience in microbiology, biochemistry, immunology, microbiota and probiotics, and will join [...]
Microviable Therapeutics was selected to present at Anglonordic Life Science Conference 2023, taking place on April 20th in London. Exclusively selected attendees will represent the key drivers of the European life sciences growth sector. Microviable's [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]